Type 2 Diabetes

Enrolling

GPHD

This trial compares the efficacy and safety of tirzepatide once weekly at either 5 mg, 10 mg, 15 mg dose to 3 times a day Lispro in patients with type 2 diabetes on glargine.

Can’t find a study that works for you?

Subscribe for Information on Other Studies

Fill out the form below an we will let you know when a study becomes available that you may be interested in:

Interested in other Studies
What other studies are you interested in?